Le Lézard
Classified in: Health
Subject: RCL

Food Safety Warning - Consumption of Our Father's Farm brand Extremely Bitter Apricot Kernels may cause cyanide poisoning


Product photos are available: https://inspection.canada.ca/food-recall-warnings-and-allergy-alerts/2021-03-26/eng/1616809509824/1616809515601

OTTAWA, March 26, 2021 /CNW/ - The Canadian Food Inspection Agency (CFIA) is warning the public not to consume and retailers, restaurants and institutions not to sell or use the product described below due to natural toxin amygdalin. Consumers should not consume the product described below as it contains excessive amygdalin which may cause acute cyanide poisoning.

The following product may have been sold nationally.

Product

Brand

Product

Size

UPC

Codes

Our Father's Farm

Extremely Bitter

Apricot Kernels

227 g

7 18122 91750 1

Best Before 7-7-2022

What you should do

If you think you became sick from consuming a food product, call your doctor.

Check to see if you have the affected product in your home or establishment. If the affected product is in your home or establishment, do not consume, sell, or use it.

Apricot kernels naturally contain amygdalin, which can release cyanide after being eaten. The human body can eliminate small amounts of cyanide, but larger amounts can result in cyanide poisoning, which could lead to death.

Symptoms of cyanide poisoning include weakness and confusion, anxiety, restlessness, headache, nausea, difficulty breathing and shortness of breath, loss of consciousness, seizures and cardiac arrest.

Background

This warning was triggered by CFIA test results. The CFIA is conducting a food safety investigation, which may lead to the recall of these or other products. If products are recalled, the CFIA will notify the public through a Food Recall Warning.

Illnesses

There have been no reported illnesses associated with the consumption of this product.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: